XXXX -192 implantation for T1 and T2a @entity5772 : retrospective study of the results of treatment at the Royal Berkshire Hospital.

@entity1 @entity137 @entity5 @entity3201 @entity5772
@entity5772 are relatively rare @entity5 , which may be treated using several modalities. We reviewed the results of @entity3201 wire implants performed at the Royal Berkshire Hospital between 1994 and 2000. 24 @entity1 had iridium wire implants as primary treatment for @entity5 . Four @entity1 were treated after excision biopsy with close or involved margins. One @entity1 was treated for a recurrence after surgery. The median age at treatment was 61 years. There were 18 @entity1 and 11 @entity1 . 21 @entity1 had @entity5 of the tongue and eight of the floor of mouth. 13 had T1 @entity5 and 11 had T2a @entity5 . The median follow up was 42 months. The primary @entity5 was controlled in 22 of the 29 @entity1 by the implant alone. Of the seven @entity1 with local recurrence four were successfully salvaged with surgery. The acturarial 2 year survival rates were: overall survival 81%, disease specific survival 91%, local recurrence free survival 85% and nodal relapse free survival 76%. The recorded complication rate was low, one @entity1 developing radionecrosis of the mandible at 7 years post implant. We believe these results show that brachytherapy remains a treatment option for @entity1 with early @entity5772 with a high rate of local control and low @entity137 .
